Published in Heart Disease Weekly, May 2nd, 2006
"This board consists of preeminent experts in their respective fields who are recognized as pioneers in cardiovascular medicine and clinical research," said Alex M. Milstein, MD, vice president of clinical development for Cytori Therapeutics. "I am delighted that these distinguished clinicians and scientists have agreed to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.